Betashares Nasdaq 100 Equal Weight Etf fund (ASX:QNDQ)
Australia · Delayed Price · Currency is AUD 16.94
-0.06 (-0.35%)
At close: Dec 30, 2025
3.93% (1Y)
| Assets | n/a |
| Expense Ratio | 0.48% |
| PE Ratio | 27.14 |
| Dividend (ttm) | 0.26 |
| Dividend Yield | 1.56% |
| Ex-Dividend Date | Jul 1, 2025 |
| Payout Frequency | Semi-Annual |
| Payout Ratio | 42.39% |
| 1-Year Return | +5.60% |
| Volume | 11,200 |
| Open | 17.02 |
| Previous Close | 17.00 |
| Day's Range | 16.94 - 17.03 |
| 52-Week Low | 13.94 |
| 52-Week High | 17.66 |
| Beta | n/a |
| Holdings | 10 |
| Inception Date | Feb 20, 2024 |
About QNDQ
QNDQ.AX was created on 2024-02-20 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. QNDQ.AX aims to track the performance of the Nasdaq-100 Equal Weighted Index (before fees and expenses).
Asset Class Equity
Category Large Cap
Stock Exchange Australian Securities Exchange
Ticker Symbol QNDQ
Provider BetaShares
Index Tracked NASDAQ-100 Equally Weighted Index
Performance
QNDQ had a total return of 5.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.00%.
Top 10 Holdings
12.89% of assets| Name | Symbol | Weight |
|---|---|---|
| Micron Technology, Inc. | MU | 1.41% |
| Advanced Micro Devices, Inc. | AMD | 1.36% |
| Regeneron Pharmaceuticals, Inc. | REGN | 1.32% |
| Applied Materials, Inc. | AMAT | 1.31% |
| Intuitive Surgical, Inc. | ISRG | 1.31% |
| Biogen Inc. | BIIB | 1.27% |
| Intel Corporation | INTC | 1.24% |
| Warner Bros. Discovery, Inc. | WBD | 1.23% |
| AstraZeneca PLC | AZN | 1.22% |
| Lam Research Corporation | LRCX | 1.22% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 1, 2025 | 0.25214 AUD | Jul 16, 2025 |
| Jan 2, 2025 | 0.0124 AUD | Jan 17, 2025 |
| Jul 1, 2024 | 0.24535 AUD | Jul 16, 2024 |